(new: share price, experts and details)
FRANKFURT (dpa-AFX) - Fresenius shares jumped to their highest level since November 2021 on Wednesday after business figures. The shares of the Bad Homburg-based company have gained around 17 percent in the current year, even outperforming the DAX with its record chase. On Wednesday morning, they led the very firm German benchmark index with a gain of seven percent.
"Fresenius is doing what it has to do," commented UBS expert Graham Doyle on the annual results. The fourth quarter results were strong and the outlook was reassuringly "good enough".
His colleague David Adlington from JPMorgan went into more detail and praised the increased margin forecast for Kabi, the infusion and transfusion specialist under the Fresenius umbrella. The company is now expected to achieve a margin of 16 to 18 percent, after profitability there had recently risen significantly thanks to cost-cutting efforts. According to Adlington, the market consensus is at the lower end. He also expected a positive reaction because Fresenius intends to pay a dividend again after a break.
In the long-term price chart, the trend reversal continues to take shape. After the shares roughly quartered from their 2017 high of around 80 euros by the fall of 2022, they now cost 39 euros again. Around a third of the losses have thus been made up./ag/ajx/jha/
